Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
Clinical trial NCT03042572 · UNKNOWN
Trial details
- NCT number
- NCT03042572
- Sponsor
- Martin Teraa, MD, PhD
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.